20/20 GeneSystems is a privately held corporation based in Maryland.   To date, the company has raised over $4.7 million in private investments.  Additional funding has been secured through numerous government and private grants to fund its research and product development.  These grants provide a ongoing source of funding and do not have a dilutive effect on shareholder investments.    The State of Maryland is offering  a tax credit or refund to individuals investing in Maryland biotechnology companies of  50% of their investment.  Investors  in 20/20 GeneSystems may be  able to take advantage of this opportunity.  For 2010, the State of Maryland has increased the tax credit pool to $8 million.  It is available to investors on a first come, first serve basis.   Investors need not be residents of Maryland to quality for this program.  For more information regarding the Maryland Biotech Tax Credit, click here

Information about investing in the company is made available to prospective accredited investors.  Presentations are made periodically throughout the year at the company’s offices.  For more information, please contact Alysa Dortort at (240) 453-6339 x100 or email at adortort@2020gene.com